Literature DB >> 21529763

Corneal cross-linking with hypo-osmolar riboflavin solution in thin keratoconic corneas.

Frederik Raiskup1, Eberhard Spoerl.   

Abstract

PURPOSE: To evaluate the 1-year results of keratoconic eyes with thin corneas that were treated by a hypo-osmolar riboflavin solution and ultraviolet A collagen cross-linking (CXL).
DESIGN: Retrospective, nonrandomized study.
METHODS: setting: Department of Ophthalmology, Carl Gustav Carus University Hospital, Dresden, Germany. study population: Thirty-two eyes of 29 patients with progressive keratoconus and a corneal thickness of less than 400 μm (without the epithelium). intervention: Application of a hypo-osmolar riboflavin solution to the cornea after its de-epithelization followed by ultraviolet A collagen cross-linking. main outcome measures: Thirty-two eyes with a follow-up within 1 year were evaluated before and after the procedure. Examinations comprised an evaluation of visual acuity, corneal topography, slit-lamp microscopy, and corneal thickness measurements.
RESULTS: Before surgery, the mean corneal thickness (with the epithelium) was 382.3 ± 41.9 μm, and after the removal of epithelium, the thickness of the cornea was reduced to 337.0 ± 51.9 μm. After the application of the hypo-osmolar riboflavin solution, this value increased to 451.8 ± 46.7 μm. Before surgery, the mean K-value of the apex of the keratoconus was 65.6 ± 11.2 diopters, and 1 year after treatment, this value remained unchanged at 64.9 ± 11.0 diopters (P = .839). Mean best-corrected visual acuity at the time of the treatment was 0.63 ± 0.37 logarithm of the minimal angle of resolution, and 1 year after the treatment, this value was not statistically different (0.59 ± 0.42 logarithm of the minimal angle of resolution; P = .662). At the last follow-up examination, which was 1 year after the procedure, all corneas were transparent, without any scarring lesions in the stroma.
CONCLUSIONS: The results of our study, using hypo-osmolar riboflavin solution in a cross-linking procedure of thin corneas, show a stability of keratoconus one year after cross-linking. Application of the hypo-osmolar riboflavin solution preserved cross-linked corneas from developing stromal scars.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529763     DOI: 10.1016/j.ajo.2011.01.016

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  30 in total

1.  Corneal collagen crosslinking for keratoconus or corneal ectasia without epithelial debridement.

Authors:  N Hirji; E Sykakis; F C Lam; R Petrarca; S Hamada; D Lake
Journal:  Eye (Lond)       Date:  2015-03-20       Impact factor: 3.775

2.  A short-term study of corneal collagen cross-linking with hypo-osmolar riboflavin solution in keratoconic corneas.

Authors:  Shao-Feng Gu; Zhao-Shan Fan; Li-Hua Wang; Xiang-Chen Tao; Yong Zhang; Chun-Qin Wang; Ya Wang; Guo-Ying Mu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

Review 3.  Corneal collagen cross-linking: a review.

Authors:  David P S O'Brart
Journal:  J Optom       Date:  2014-03-20

Review 4.  [Riboflavin UVA crosslinking in progressive keratoconus].

Authors:  P Maier; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

Review 5.  Safety and efficacy of epithelium removal and transepithelial corneal collagen crosslinking for keratoconus.

Authors:  Z Shalchi; X Wang; M A Nanavaty
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

6.  Long-term visual, refractive, tomographic and aberrometric outcomes of corneal collagen crosslinking (CXL) with or without hypoosmolar riboflavin solution in the treatment of progressive keratoconus patients with thin corneas.

Authors:  Tuna Celik Buyuktepe; Omur O Ucakhan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-27       Impact factor: 3.117

7.  [Riboflavin UVA cross-linking for keratoconus].

Authors:  P Maier; T Reinhard
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

8.  Success of hydrocone (TORIS-K) soft contact lens for keratoconus and traumatic keratopathy.

Authors:  Ahmet Altun; Sevda Aydin Kurna; Tomris Sengor; Gulengul Altun; Osman Okan Olcaysu; Mert Hakan Simsek
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

9.  Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?

Authors:  Igor Knezović; Mirna Belovari Višnjić; Hrvoje Raguž
Journal:  Case Rep Ophthalmol Med       Date:  2015-04-30

10.  Safety and efficacy of epithelium-on corneal collagen cross-linking using a multifactorial approach to achieve proper stromal riboflavin saturation.

Authors:  Aleksandar Stojanovic; Xiangjun Chen; Nan Jin; Ting Zhang; Filip Stojanovic; Sten Raeder; Tor Paaske Utheim
Journal:  J Ophthalmol       Date:  2012-07-30       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.